Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Nov/14/2020 Nov/27/2020 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/13/2020 Nov/24/2020 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/13/2020 Nov/24/2020 0
Baricitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/13/2020 Nov/27/2020 0
Fluvoxamine Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/12/2020 Nov/24/2020 0
Vitamin D3 Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/12/2020 Nov/24/2020 0
Saquinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/12/2020 Nov/24/2020 0
Interferon beta-1a Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/12/2020 Nov/27/2020 0
Acarbose Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/12/2020 Nov/24/2020 0
Hyaluronic acid Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/12/2020 Nov/24/2020 0